エストニア - エストニア語 - Ravimiamet

aziende chimiche riunite angelini francesco - a.c.r.a.f. s.p.a. - fentanüül - keelealune tablett - 267mcg 15tk; 267mcg 30tk

エストニア - エストニア語 - Ravimiamet

novartis baltics sia - karbamasepiin - toimeainet prolongeeritult vabastav tablett - 400mg 30tk

エストニア - エストニア語 - Ravimiamet

desitin arzneimittel gmbh - karbamasepiin - toimeainet prolongeeritult vabastav tablett - 600mg 50tk; 600mg 100tk

エストニア - エストニア語 - Ravimiamet

oÜ baxter estonia - tsüklofosfamiid - süstelahuse pulber - 1g 1tk

欧州連合 - エストニア語 - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastilised ained - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

エストニア - エストニア語 - Ravimiamet

lex ano uab - sertraliin - õhukese polümeerikattega tablett - 50mg 28tk

エストニア - エストニア語 - Ravimiamet

besins healthcare ireland limited - progesteroon - vaginaalpehmekapsel - 300mg 15tk

欧州連合 - エストニア語 - EMA (European Medicines Agency)

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastilised ained - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

欧州連合 - エストニア語 - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastilised ained - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

エストニア - エストニア語 - Ravimiamet

ideal trade links uab - sertraliin - õhukese polümeerikattega tablett - 100mg 28tk; 100mg 14tk